
Scripted for Her: Combatting Polyendocrine Metabolic Ovarian Syndrome
Lucy Andrews, PharmD, breaks down the new name for polycystic ovary syndrome and explains how pharmacists can help women get answers sooner.
For years, polycystic ovary syndrome (PCOS) was framed mainly as an ovarian disorder, and that framing often led to missed or delayed diagnoses. In May 2026, after a global consensus process involving more than 50 patient and professional organizations, the condition was officially renamed polyendocrine metabolic ovarian syndrome (PMOS).
On the latest episode of Scripted for Her, Lucy Andrews, PharmD, pharmacist and hormone consultant at the Central Ohio Compounding Pharmacy, explains why the new name better reflects what patients experience and where pharmacists fit on the interdisciplinary care team.
“One of the biggest changes that they made was including ‘metabolic’ in the name, because insulin resistance is really foundational to PMOS,” Andrews said.
Along with host Natalie DiPietro Mager, PharmD, PhD, they walk through each part of the new name, the wide range of symptoms that complicate diagnosis, and practical ways pharmacists can counsel patients on insulin resistance, gut health, hormone testing, and more.
READ MORE:
Unpacking the New Name
Andrews explains that each part of the new name was chosen on purpose. "Polyendocrine" reflects the involvement of several hormonal systems, including metabolic and neuroendocrine pathways, not just ovarian ones. Adding "metabolic" was one of the biggest changes because of insulin resistance, and the cardiovascular health concerns that come with it are foundational to the condition. "Ovarian" stays in the name, but the ovaries are no longer the sole focus. And finally, "syndrome" describes a group of related signs, symptoms, and health patterns rather than one defining feature.
PMOS affects about 1 in 8 women worldwide and presents differently in each patient. Symptoms fall into connected categories: Excess androgens can cause acne, unwanted hair growth on the chin, back, and abdomen, and hair loss on the scalp. Metabolic factors include insulin resistance, obesity, hypertension, dyslipidemia, and sleep apnea. Andrews notes that insulin resistance drives excess androgen production, which disrupts ovulation and can lead to irregular menstrual cycles and infertility.
Patients aged 20 years and older need 2 of 3 criteria for diagnosis: ovulatory changes, hyperandrogenism, or polycystic ovaries on ultrasound. Patients younger than 20 years must meet the first 2.
Closing Gaps in Diagnosis and Treatment
Although guidelines were updated in 2023, before the name change, Andrews says that knowledge of how to handle patients with these varied symptoms hasn't fully reached clinical practice. As a result, much of the burden still falls on patients to advocate for themselves.
She would like to see more emphasis on insulin resistance, including diet and its effect on glucose levels, alongside existing options such as metformin and newer GLP-1 therapies. She also calls for more comprehensive baseline hormone testing.
In her view, oral contraceptives often mask symptoms such as acne rather than address the root cause.
Pharmacist-Led Counseling and Support
As the most accessible health care providers, pharmacists are well placed to support younger patients whose symptoms may be dismissed as normal hormonal changes.
Andrews says insulin resistance can develop well before prediabetes, so checking fasting insulin and fasting glucose can reveal problems even when hemoglobin A1C looks normal. She recommends patient-friendly resources such as the Glucose Goddess, who teaches simple strategies like pairing starches with fat or protein to blunt glucose spikes.
She also counsels patients on gut health and suggests food diaries to help identify foods that cause bloating or discomfort. She calls on practitioners to evaluate a broader hormone panel: progesterone, estrogen, testosterone, DHEA, sex hormone–binding globulin, LH, and FSH. To manage stress-related inflammation, Andrews recommends a varied diet, good hydration, and 15 to 20 minutes a day of a mindfulness activity in which patients “lose track of time.”
Above all, she encourages pharmacists to help patients keep speaking up until they get the care they need. A 3-year global implementation strategy for the new name is underway, so pharmacists should watch for new educational materials as they release.
Check out these additional resources to learn more:
Glucose Goddess A Functional Medicine PCOS Protocol: Comprehensive Testing, Therapeutic Diet, and Supplements
Related to this article








